News

Education loan growth is set to halve this fiscal (FY26) because disbursements for the US decelerate following a raft of ...
FY26 company results, July 11: 14 companies will be releasing their performance reports for the April-June quarter today ...
The 92,400oz produced for the full year FY25 was nonetheless 32% up on FY24, and OBM is set for a head start in FY26, with ...
TCS shares have underperformed their large Indian peers on a YTD, 1-year, 2-year, 3-year, and 5-year basis. This ...
A total of 14 companies are set to announce their results for the first quarter of FY26 on July 11. Avenue Supermarts Ltd., ...
Tata Consultancy Services Ltd., Hindustan Unilever Ltd., Bharat Forge Ltd., and Glenmark Pharma Ltd. were among the top ...
Tata Consultancy Services reported a net profit of Rs 12,760 crore for Q1 FY2025-26, a 6% increase year-over-year, exceeding ...
Discover Jefferies' latest 11 value stock picks for India—see the new entrants and key insights to update your portfolio today!
Anand Rathi Wealth reports strong financial performance with 28% jump in PAT, high net inflows, and revenue guidance.
Shares of Tata Consultancy Services (TCS) dropped 2.51 per cent on Friday morning trade after its June quarter earnings ...
A final word. For FY26, the cumulative SIP stoppage ratio at 151.51% is still largely influenced by the April spike impact.
Indian pharmaceutical companies are expected to sustain their growth momentum into FY26, supported by strong performance in the US generics market, ongoing drug shortages, and robust demand in India’s ...